HurtapS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-06-28
Share capital
10 147 500,00 PLN
Activity description

Hurtap is a pharmaceutical distribution company that supplies medications and medical materials to nearly 10,000 pharmacies across Poland. With 35 years of experience in the pharmaceutical market, it holds approximately 9% of the wholesale market share in Poland. The company emphasizes high standards and efficiency in its operations to meet customer demands.

Registered address
Górnicza 2, 99-100 Łęczyca, Poland
Website
hurtap.com.plWebsite active
Email
Email inactive
Phone
Electronic delivery address
AE:PL-31321-44624-BFUSG-24

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 480.28mMedianUSD 874.32kAverageUSD 20.00m
Net profit
This companyUSD 958.07kMedianUSD 28.20kAverageUSD 813.32k
Operating costs
This companyUSD 471.87mMedianUSD 803.36kAverageUSD 18.76m
Assets
This companyUSD 165.78mMedianUSD 541.39kAverageUSD 10.63m

Bank accounts

Registered as a VAT taxpayer on 1999-12-12. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

26 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Jun 3, 2026Shareholders' meeting convened
Jun 3, 2025Shareholders' meeting convened
Dec 6, 2024Shareholders' meeting convened
Oct 23, 2024Shareholders' meeting convened
May 16, 2024Shareholders' meeting convened

Public aid

25 public aid cases recorded, with a total value of $3,627,022.

Grant datePurposeGross amountGranting body
May 28, 2024
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,013Starosta Powiatu Łęczyca
Mar 8, 2024
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,289Starosta Powiatu Łęczyca
Mar 8, 2024
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,922Starosta Powiatu Łęczyca

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Alicja Marta Napióra — Vice President of the Management Board
Małgorzata Keller — Attorney-in-fact (sole)
Wiktor Napióra — President of the Management Board

Manner of representation

If a multi-member management board is appointed, each member of the management board represents the company independently.

Supervisory board

Krzysztof Biernacki — Supervisory Board Member
Daria Orszulak Michalak — Supervisory Board Member
Wojciech Łazor — Supervisory Board Member

Beneficial owners

PersonRights
Wiktor Napióra (71)
Shareholder of a joint-stock company, 75.85%

Competitors

NameRevenueWebsite
Bayersp. z o.o.$624,313,880.67bayer.pl
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.$600,815,720.02slawex.com.pl
Farutexsp. z o.o.$501,280,398.45farutex.pl
Centrala Farmaceutyczna CefarmS.A.$457,052,669.59cefarm.com.pl
Onninensp. z o.o.$410,385,925.20onninen.pl
Sanofisp. z o.o.$384,123,246.36sanofi.pl
USP Zdrowiesp. z o.o.$377,149,656.94uspzdrowie.pl
PHUP Gniezno Szeszyckisp. k.$364,107,303.64phupgniezno.pl
NovoS.A.$209,522,261.96novo-sa.pl
Bialmedsp. z o.o.$203,238,055.12bialmed.pl

Change history

DateEvent
2004-10-21Share capital change (9,477,500.00 PLN → 10,147,500.00 PLN)
2003-06-12Share capital change (9,177,500.00 PLN → 9,477,500.00 PLN)
2001-07-27Share capital change (8,100,000.00 PLN → 9,177,500.00 PLN)
2001-06-28Entered in the register

FAQ

Last updated: 2026-07-15